PrEP, or Pre-Exposure Prophylaxis, is a medication used to reduce acquiring HIV (Human Immunodeficiency Virus) in persons who are HIV-negative.
When used as prescribed, PrEP reduces the risk of acquiring HIV from sex by about 99% and reduces the risk of acquiring HIV from injection drug use by 74%.
Because PrEP only protects against HIV, condom use is still recommended for protection against other STIs (sexually transmitted infections). If PrEP is not being used, condom use is also recommended to help prevent HIV transmission.
The most common form of PrEP includes taking a daily pill containing two antiretroviral drugs such as Truvada (emtricitabine & tenofovir disoproxil fumarate) or Descovy (emtricitabine & tenofovir alafenamide). Another alternative would be long-acting injectable PrEP such as Apretude (cabotegravir) which is injected by a healthcare provider every month for the first two months, and then every two months thereafter.
“The U.S. Food and Drug Administration (FDA) approved the first drug for pre-exposure prophylaxis (PrEP), Truvada, to reduce the risk of HIV infection in adults on July 16, 2012.”
There are several factors to consider when determining if PrEP is right for you.
If you think PrEP is right for you, schedule an appointment and talk to your provider. Your provider will complete a risk assessment, complete HIV/STI & safety laboratory testing, and discuss treatment options.
Once prescribed PrEP, you’ll need to have routine testing and provider visits at least every 3 months. Be sure to follow up with your provider to coordinate those visits with your refills as needed.
Most insurances cover PrEP as preventative care and there may be some copay assistance and patient assistance programs available to help reduce costs.